Key result
EV71 vaccination of every 100,000 children ≤ 5 years decreased the effective reproduction number of EV71-associated HFMD by 14.44% (95% CI: 6.76%-21.42%).
Why the study?
The effect of Enterovirus A71 (EV71) vaccination on the transmissibility of different enterovirus serotypes of hand, foot, and mouth disease was unknown.
Does EV71 vaccination reduce the transmissibility of hand, foot, and mouth disease in children ≤ 5 years old?
Observational
Does EV71 vaccination reduce the transmissibility of hand, foot, and mouth disease in children ≤ 5 years old?
Effect estimate: 14.44% decrease (95% CI 6.76%-21.42%)
EV71 vaccination significantly reduces the transmissibility of EV71-associated HFMD, with an estimated 54.51% vaccine coverage needed to prevent epidemics in Zhejiang.
EV71 vaccination may alter HFMD serotype transmissibility via Rt; leaves open need for prospective studies before policy impact.
Objective: To investigate the effect of Enterovirus A71 (EV71) vaccination on the transmissibility of different enterovirus serotypes of hand, foot, and mouth disease (HFMD) in Zhejiang, China. Methods: Daily surveillance data of HFMD and EV71 vaccination from August 2016 to December 2019 were collected. Epidemic periods for each HFMD type were defined, and the time-varying effective reproduction number (Rt) was estimated, which could provide more direct evidence of disease epidemics than case number. General additive models (GAMs) were employed to analyze associations between EV71 vaccination quantity and rate and HFMD transmissibility. The epidemic prevention threshold, represented by required vaccination numbers and rates, was also estimated. Results: Vaccinating every 100,000 children ≤ 5 years could lead to a decrease in the Rt of EV71-associated HFMD by 14.44% (95%CI: 6.76%, 21.42%). Additionally, a positive correlation was observed between vaccinations among children ≤ 5 years old (per 100,000) and the increased transmissibility of other HFMD types (caused by enteroviruses other than EV71 and CA16) at 1.82% (95%CI: 0.80%, 2.84%). It was estimated that an additional 362,381 vaccinations, corresponding to increased vaccine coverage to 54.51% among children ≤ 5 years could effectively prevent EV71 epidemics in Zhejiang. Conclusions: Our findings highlight the importance of enhancing EV71 vaccine coverage for controlling the epidemic of EV71-HFMD and assisting government officials in developing strategies to prevent HFMD.
No takes yet. Share an insight, caveat, or question.
Zheng et al. (2024) conducted an observational in Hand, foot, and mouth disease (HFMD). EV71 vaccination was evaluated on Time-varying effective reproduction number (Rt) of EV71-associated HFMD (14.44% decrease, 95% CI 6.76%-21.42%). EV71 vaccination of every 100,000 children ≤ 5 years decreased the effective reproduction number of EV71-associated HFMD by 14.44% (95% CI: 6.76%-21.42%).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: